A detailed history of Capital World Investors transactions in Novo Cure LTD stock. As of the latest transaction made, Capital World Investors holds 4,308,218 shares of NVCR stock, worth $76.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,308,218
Previous 2,308,215 86.65%
Holding current value
$76.4 Million
Previous $39.5 Million 70.31%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.61 - $23.34 $31.2 Million - $46.7 Million
2,000,003 Added 86.65%
4,308,218 $67.3 Million
Q1 2024

May 14, 2024

SELL
$12.42 - $17.29 $12 Million - $16.8 Million
-968,781 Reduced 29.56%
2,308,215 $36.1 Million
Q4 2023

Feb 13, 2024

SELL
$11.13 - $15.78 $62.3 Million - $88.4 Million
-5,601,735 Reduced 63.09%
3,276,996 $48.9 Million
Q3 2023

Nov 13, 2023

SELL
$16.15 - $42.35 $40.6 Million - $106 Million
-2,511,814 Reduced 22.05%
8,878,731 $143 Million
Q2 2023

Aug 11, 2023

SELL
$40.29 - $82.51 $106 Million - $217 Million
-2,634,512 Reduced 18.78%
11,390,545 $473 Million
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $66.3 Million - $140 Million
1,175,538 Added 9.15%
14,025,057 $843 Million
Q4 2022

Feb 14, 2023

BUY
$63.98 - $85.37 $3.92 Million - $5.23 Million
61,280 Added 0.48%
12,849,519 $943 Million
Q3 2022

Nov 14, 2022

BUY
$67.99 - $89.57 $72.5 Million - $95.5 Million
1,065,755 Added 9.09%
12,788,239 $972 Million
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $52.5 Million - $83.4 Million
-928,159 Reduced 7.34%
11,722,484 $815 Million
Q1 2022

May 16, 2022

BUY
$60.15 - $84.52 $1.6 Million - $2.25 Million
26,600 Added 0.21%
12,650,643 $1.05 Billion
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $266,008 - $432,210
3,543 Added 0.03%
12,624,043 $948 Million
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $90 Million - $151 Million
774,799 Added 6.54%
12,620,500 $1.47 Billion
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $418 Million - $724 Million
3,208,178 Added 37.14%
11,845,701 $2.63 Billion
Q1 2021

May 14, 2021

BUY
$124.11 - $190.17 $111 Million - $170 Million
892,485 Added 11.52%
8,637,523 $1.14 Billion
Q4 2020

Feb 12, 2021

BUY
$112.16 - $174.14 $125 Million - $194 Million
1,115,021 Added 16.82%
7,745,038 $1.34 Billion
Q3 2020

Nov 13, 2020

BUY
$58.05 - $111.31 $77 Million - $148 Million
1,326,769 Added 25.02%
6,630,017 $738 Million
Q2 2020

Aug 14, 2020

BUY
$57.2 - $74.41 $21 Million - $27.4 Million
367,900 Added 7.45%
5,303,248 $314 Million
Q1 2020

May 15, 2020

SELL
$57.05 - $95.75 $5.7 Million - $9.57 Million
-99,972 Reduced 1.99%
4,935,348 $332 Million
Q4 2019

Feb 18, 2020

BUY
$68.3 - $93.8 $33,535 - $46,055
491 Added 0.01%
5,035,320 $424 Million
Q3 2019

Nov 14, 2019

SELL
$61.86 - $97.8 $12.4 Million - $19.6 Million
-199,983 Reduced 3.82%
5,034,829 $377 Million
Q2 2019

Aug 14, 2019

BUY
$42.22 - $63.23 $8.46 Million - $12.7 Million
200,415 Added 3.98%
5,234,812 $331 Million
Q1 2019

May 15, 2019

BUY
$31.96 - $56.12 $71.6 Million - $126 Million
2,240,586 Added 80.2%
5,034,397 $243 Million
Q4 2018

Feb 14, 2019

BUY
$28.72 - $52.63 $15.2 Million - $27.8 Million
528,500 Added 23.33%
2,793,811 $93.5 Million
Q3 2018

Nov 14, 2018

BUY
$32.0 - $52.4 $12.4 Million - $20.3 Million
386,600 Added 20.58%
2,265,311 $119 Million
Q2 2018

Aug 14, 2018

BUY
$19.85 - $32.0 $37.3 Million - $60.1 Million
1,878,711 New
1,878,711 $58.8 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.